GTS Securities’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
GTS Securities's RVMD Position: Q3 2026 in Review
GTS Securities sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 1,151 shares — an estimated $216K sold.
GTS Securities first reported a position in RVMD in Q2 2026 and held it in 1 quarter. The position peaked at $216K in Q2 2026. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- GTS Securities reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
- GTS Securities sold 1,151 Revolution Medicines shares in Q3 2026, an estimated $216K.
- GTS Securities first reported a position in Revolution Medicines in Q2 2026 and held it in 1 quarter.
- GTS Securities's Revolution Medicines position peaked at $216K in Q2 2026.
- 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.